产品详情
简单介绍：
GSK5959,BRPF1BromodomainInhibitor
详情介绍：
Product Information
| Molecular Weight: | 394.47 |
| Formula: | C22H26N4O3 |
| Purity: | ≥98% |
| CAS#: | 901245-65-6 |
| Solubility: | DMSO up to 10 mM |
| Chemical Name: | N-(1,3-dimethyl-2-oxo-6-(piperidin-1-yl)-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methoxybenzamide |
| Storage: | Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year. |
Biological Activity:
GSK5959 is a potent, selective and cell permeable BRPF1 bromodomain inhibitor with IC50 ~ 80 nM. It has >100-fold selectivity for BRPF1 over a panel of 35 other bromodomains, including BRPF2/3 and BET family bromodomains. A cellular protein interaction assay measuring the displacement of NanoLuc-tagged BRPF1 bromodomain from Halotagged histone H3.3 was employed to demonstrate GSK5959’s cell permeability and disruption of chromatin binding with IC50 ~0.98 µM.
How to Use:
In vitro: GSK5959 was used at 10 µM final concentration in various in vitro assays.
In vivo: n/a
Reference:
- 1. Demont EH, et al. 1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain. (2014) ACS Med Chem Lett. 5(11):1190-5.
Products are for research use only. Not for human use.
相关文章
